Vasopressin plus oxygen vs vasopressin alone in cirrhotic patients with portal-hypertensive gastropathy: Effects on gastric mucosal haemodynamics and oxygenation

Journal of Gastroenterology and Hepatology (Australia)

Volumn 11, Issue 3, 1996, Pages 216-222

  Iwao, Tadashi ^a,b   Toyonaga, Atsushi ^a   Shigemori, Hiroyuki ^a   Oho, Kazuhiko ^a   Sumino, Michihiro ^a   Sato, Masahiro ^a   Tanikawa, Kyuichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY HOSPITAL   (Japan)

Author keywords

Gastric mucosal haemodynamics; Portal hypertensive gastropathy; Vasopressin; Vasopressin plus oxygen

Indexed keywords

PLACEBO; VASOPRESSIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENDOSCOPY; FEMALE; HUMAN; HYPOXIA; INTRAVENOUS DRUG ADMINISTRATION; LASER DOPPLER FLOWMETRY; LIVER CIRRHOSIS; MALE; OXYGENATION; PORTAL HYPERTENSION; PRIORITY JOURNAL; STOMACH DISEASE; STOMACH MUCOSA BLOOD FLOW;

EID: 0029929566     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1996.tb00065.x     Document Type: Article

References (38)

1. D'Amico G, Montalbano L, Traina M et al. Natural history of congestive gastropathy in cirrhosis. Gastroenterology 1990; 99: 1558-64.
2. Sato N, Kamada T, Shichiri M, Kawano S, Abe H, Hagihara B. Measurement of hemoperfusion and oxygen sufficiency in gastric mucosa in vivo. Evidence of mucosal hypoxia as the cause of hemorrhagic shock-induced gastric mucosal lesion in rats. Gastroenterology 1979; 76: 814-19.
3. Shepherd AP, Riedel GL. Continuous measurements of intestinal mucosal blood flow by laser Doppler velocimetry. Am. J. Physiol. 1982; 242: G668-72.
4. Toyonaga A, Iwao T, Shimotsuura Y, Tanikawa K. Endoscopic histologic and hemodynamic studies on portal hypertensive gastric mucosa. J. Gastroenterol. Hepatol. 1989; 4 (Suppl. 1): 132-5.
5. Sato N, Kawano S. Gastric mucosal microcirculation disturbances in portal hypertension. J. Gastroenterol. Hepatol. 1989; 4 (Suppl. 1): 78-80.
6. Adachi H, Mitsunaga A, Yokoyama S et al. The study of gastric mucosal changes and their mechanism in patients with liver cirrhosis. J. Gastroenterol. Hepatol. 1989; 4 (Suppl. 1): 96-8.
7. Panés J, Bordas JM, Piqué JM et al. Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. Gastroenterology 1992; 103: 1875-82.
8. Iwao T, Toyonaga A, Ikegami M et al. Reduced gastric mucosal blood flow in patients with portal-hypertensive gastropathy. Hepatology 1993; 18: 36-40.
9. Almond NE, Wheatley AM. Measurement of hepatic perfusion in rats by laser Doppler flowmetry. Am. J. Physiol. 1992; 262: G203-9.
10. Panés J, Piqué JM, Bordas JM et al. Reduction of gastric hyperemia by glypressin and vasopressin administration in cirrhotic patients with portal hypertensive gastropathy. Hepatology 1994; 19: 55-60.
11. Sarfeh IJ, Soliman H, Waxman K et al. Impaired oxygen of gastric mucosa in portal hypertension. The basis for increased susceptibility to injury. Dig. Dis. Sci. 1989; 34: 225-8.
12. Casadevall M, Panés J, Piqué JM, Bosch J, Terés J, Rodés J. Limitations of laser-Doppler velocimetry and reflectance spectrophotometry in estimating gastric mucosal blood flow. Am. J. Physiol. 1992; 263: G810-15.
13. Pugh RNH, Murray-Lyron M, Dawson JL, Pietroni MC, Williams R. Transection of oesophagus for bleeding oesophageal varices. Br. J. Surg. 1973; 60: 646-9.
14. Iwao T, Toyonaga A, Ikegami M et al. McCormack's endoscopic signs for diagnosing portal hypertension: Comparison with gastroesophageal varices. Gastrointest. Endosc. 1994; 40: 470-3.
15. Iwao T, Toyonaga A, Harada H et al. Arterial oxygen desaturation during non-sedated diagnostic esophagogastroduodenoscopy in cirrhosis. Gastrointest. Endosc. 1994; 40: 281-4.
16. Christoforidis EC, Hovendal C, Bjerring P, Kruse A. Continuous measurement of gastric blood flow by laser-Doppler flowmetry during endoscopy. Scand. J. Gastroemerol. 1989; 24: 16-20.
17. Iwao T, Toyonaga A, Ikegami M et al. Gastric mucosal blood flow after smoking in healthy human beings assessed by laser Doppler flowmetry. Gastrointest. Endosc. 1993; 39: 400-3.
18. Iwao T, Toyonaga A, Ikegami M et al. Observer agreement and variability in measuring gastric mucosal blood flow by laser Doppler flowmetry in humans. Endoscopy 1993; 25: 274-7.
19. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ. Res. 1980; 47: 1-9.
20. Leung FW, Jensen DM, Guth PH. Endoscopic demonstration that vasopressin but not propranolol produces gastric mucosal ischemia in dogs with portal hypertension. Gastrointest. Endosc. 1988; 34: 310-13.
21. Leung FW, Slodownik E, Jensen DM, VanDeventer GM, Guth PH. Gastroduodenal mucosal hemodynamics by endoscopic reflectance spectrophotometry. Gastrointest. Endosc. 1987; 33: 284-8.
22. Iwao T, Toyonaga A, Sumino M et al. Effects of vaso-active agents on hepatic function and blood gases in patients with cirrhosis: A study of vasopressin and nitroglycerin. J. Gastroenterol. Hepatol. 1992; 7: 148-53.
23. Iwao T, Toyonaga A, Sumino M et al. Lack of hepatic benefit by oxygen inhalation during vasopressin infusion in patients with cirrhosis. J. Gastroenterol. Hepatol. 1992; 7: 249-52.
24. Huet PM, Valla D, Lafortune M, Marleau D. Hemodynamic effects of vasopressin in cirrhotic patients. In: Lebrec D, Blei AT, eds. Vasopressin Analogs and Portal Hypertension. Paris: John Libbey Eurotext, 1987; 83-94.
25. Blei AT, Groszmann RJ, Gusberg R, Conn HO. Comparison of vasopressin and triglycyl-lysine vasopressin on splanchnic and systemic hemodynamics in dogs. Dig. Dis. Sci. 1980; 25: 688-94.
26. Bosch J, Kravetz D, Rodés J. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver. Comparison with vasopressin. Gastroenterology 1981; 80: 518-25.
27. Groszmann RJ, Kravetz D, Bosch J et al. Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension. Hepatology 1982; 2: 757-62.
28. Pawlik W, Shephered AP, Jacobson ED. Effects of vasoconstrictive agents on intestinal oxygen consumption and blood flow in dogs. J. Clin. Invest. 1975; 56: 484-90.
29. Groszmann RJ, Blei AT, Storer EH, Conn HO. Intestinal oxygen consumption during mechanical and pharmacological reduction in portal pressure. Am. J. Physiol. 1980; 238: G502-8.
30. Koshy A, Moreau R, Cerini R et al. Effects of oxygen inhalation on tissue oxygenation in patients with cirrhosis. Evidence for an impaired arterial baroreflex control. J. Hepatol. 1989; 9: 240-5.
31. Iwao T, Toyonaga A, Sumino M et al. Portal hypertensive gastropathy in patients with cirrhosis. Gastroenterology 1992; 102: 2060-5.
32. Panés J, Bordas JM, Piqué JM et al. Effects of propranolol on gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. Hepatology 1993; 17: 213-18.
33. Shigemori H, Iwao T, Ikegami M, Toyonaga A, Tanikawa K. Effects of propranolol on gastric mucosal perfusion and serum gastrin level in cirrhotic patients with portal hypertensive gastropathy. Dig. Dis. Sci. 1994; 39: 2433-8.
34. Hosking SW, Kennedy HJ, Seddon I, Triger DR. The role of propranolol in congestive gastropathy of portal hypertension. Hepatology 1987; 7: 437-41.
35. Pérez-Ayuso RM, Piqué JM, Bosch J et al. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet 1991; 337: 1431-4.
36. Panés J, Piqué JM, Bordas JM et al. Effect of bolus injection and continuous infusion of somatostatin on gastric perfusion in cirrhotic patients with portal-hypertensive gastropathy. Hepatology 1994; 20: 336-41.
37. Slotnik JL, Teigland JD. Cardiac accidents following vasopressin injection (pitressin). JAMA 1957; 146: 1126-9.
38. Heyndricks RG, Boettcher DH, Vatner SF. Effects of angiotensin, vasopressin- and methoxamine on cardiac function and blood flow distribution in conscious dogs. Am. J. Physiol. 1976; 231: 1587-97.